predicting response to car-t therapy in lymphoma: challenges and strategies
Published 1 year ago • 85 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
1:28
the remaining hurdles for using ctdna in lymphoma
-
1:17
the importance of risk-adapted therapies in hodgkin lymphoma
-
0:49
llm lymphoma highlights: atll
-
0:55
intracranial disease in hodgkin lymphoma: a case study
-
4:23
chartese, non-hodgkin lymphoma survivor
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
7:52
린치증후군, 진단과 치료
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
11:43
will knowledge of the molecular pathology of lymphoma improve clinical trials?
-
1:03
what’s on the horizon for hodgkin lymphoma?
-
1:42
using cfdna to monitor and diagnose viral-associated lymphomas
-
1:36
re-evaluating the role of radiation therapy in lymphoma & exploring combinations with immunotherapy
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
4:04
molecular characterization of classical hodgkin lymphoma
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
5:02
treatment of lymphoma: overview of the continued progress
-
1:58
incorporating immunotherapy in the frontline & salvage treatment of hodgkin lymphoma
-
1:22
diagnostics and treatment outcomes from primary cbcl